These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

954 related articles for article (PubMed ID: 31489928)

  • 1. Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies.
    Brodehl A; Ebbinghaus H; Deutsch MA; Gummert J; Gärtner A; Ratnavadivel S; Milting H
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31489928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untangling the Biology of Genetic Cardiomyopathies with Pluripotent Stem Cell Disease Models.
    Buikema JW; Wu SM
    Curr Cardiol Rep; 2017 Apr; 19(4):30. PubMed ID: 28315121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease Modeling and Disease Gene Discovery in Cardiomyopathies: A Molecular Study of Induced Pluripotent Stem Cell Generated Cardiomyocytes.
    Kumar S; Curran JE; Kumar K; DeLeon E; Leandro AC; Peralta J; Williams-Blangero S; Blangero J
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
    Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
    Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cells in the inherited cardiomyopathies: From disease mechanisms to novel therapies.
    Ross SB; Fraser ST; Semsarian C
    Trends Cardiovasc Med; 2016 Nov; 26(8):663-672. PubMed ID: 27296521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes.
    Eschenhagen T; Mummery C; Knollmann BC
    Cardiovasc Res; 2015 Apr; 105(4):424-38. PubMed ID: 25618410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of an RBM20-mutation-associated left-ventricular non-compaction cardiomyopathy iPSC line (UMGi255-A) into a DCM genetic background to investigate monogenetic cardiomyopathies.
    Eberl H; Rebs S; Hoppe S; Sedaghat-Hamedani F; Kayvanpour E; Meder B; Streckfuss-Bömeke K
    Stem Cell Res; 2024 Feb; 74():103290. PubMed ID: 38141360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells.
    Tanaka A; Yuasa S; Node K; Fukuda K
    Int J Mol Sci; 2015 Aug; 16(8):18894-922. PubMed ID: 26274955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. iPSC-derived cardiomyocytes reveal abnormal TGF-β signalling in left ventricular non-compaction cardiomyopathy.
    Kodo K; Ong SG; Jahanbani F; Termglinchan V; Hirono K; InanlooRahatloo K; Ebert AD; Shukla P; Abilez OJ; Churko JM; Karakikes I; Jung G; Ichida F; Wu SM; Snyder MP; Bernstein D; Wu JC
    Nat Cell Biol; 2016 Oct; 18(10):1031-42. PubMed ID: 27642787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual optical recordings for action potentials and calcium handling in induced pluripotent stem cell models of cardiac arrhythmias using genetically encoded fluorescent indicators.
    Song L; Awari DW; Han EY; Uche-Anya E; Park SH; Yabe YA; Chung WK; Yazawa M
    Stem Cells Transl Med; 2015 May; 4(5):468-75. PubMed ID: 25769651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.
    Kamdar F; Klaassen Kamdar A; Koyano-Nakagawa N; Garry MG; Garry DJ
    J Card Fail; 2015 Sep; 21(9):761-70. PubMed ID: 25934595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling of human cardiomyopathy with induced pluripotent stem cells.
    Lee YK; Ng KM; Tse HF
    J Biomed Nanotechnol; 2014 Oct; 10(10):2562-85. PubMed ID: 25992409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Engineering of Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Cavanaugh C; Hesson J; Mathieu J
    Methods Mol Biol; 2024; 2735():129-143. PubMed ID: 38038847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Streckfuss-Bömeke K; Tiburcy M; Fomin A; Luo X; Li W; Fischer C; Özcelik C; Perrot A; Sossalla S; Haas J; Vidal RO; Rebs S; Khadjeh S; Meder B; Bonn S; Linke WA; Zimmermann WH; Hasenfuss G; Guan K
    J Mol Cell Cardiol; 2017 Dec; 113():9-21. PubMed ID: 28941705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies.
    Ramachandra CJA; Chua J; Cong S; Kp MMJ; Shim W; Wu JC; Hausenloy DJ
    Cardiovasc Res; 2021 Feb; 117(3):694-711. PubMed ID: 32365198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
    Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
    Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling Peripartum Cardiomyopathy With Human Induced Pluripotent Stem Cells Reveals Distinctive Abnormal Function of Cardiomyocytes.
    Naftali-Shani N; Molotski N; Nevo-Caspi Y; Arad M; Kuperstein R; Amit U; Huber I; Zeltzer LA; Levich A; Abbas H; Monserrat L; Paret G; Leor J
    Circulation; 2018 Dec; 138(23):2721-2723. PubMed ID: 30571272
    [No Abstract]   [Full Text] [Related]  

  • 18. Structural Changes in N-Glycans on Induced Pluripotent Stem Cells Differentiating Toward Cardiomyocytes.
    Kawamura T; Miyagawa S; Fukushima S; Kashiyama N; Kawamura A; Ito E; Saito A; Maeda A; Eguchi H; Toda K; Miyagawa S; Okuyama H; Sawa Y
    Stem Cells Transl Med; 2015 Nov; 4(11):1258-64. PubMed ID: 26378261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DeepNEU: cellular reprogramming comes of age - a machine learning platform with application to rare diseases research.
    Danter WR
    Orphanet J Rare Dis; 2019 Jan; 14(1):13. PubMed ID: 30630505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic recapitulation and correction of desmoglein-2-deficient cardiomyopathy using human-induced pluripotent stem cell-derived cardiomyocytes.
    Shiba M; Higo S; Kondo T; Li J; Liu L; Ikeda Y; Kohama Y; Kameda S; Tabata T; Inoue H; Nakamura S; Takeda M; Ito E; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
    Hum Mol Genet; 2021 Jul; 30(15):1384-1397. PubMed ID: 33949662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.